Related Experiment Video
Updated: Apr 23, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Congestive Heart Failure With Apparently Preserved Left Ventricular Systolic Function: A 10-Year Observational Study
Ayman El-Menyar1, Adel Shabana2, Abdulrahman Arabi3
1Department of Clinical Medicine, Weill Cornell Medical School, Doha, Qatar Clinical Research, Trauma Section, Hamad Medical Corporation (HMC), Doha, Qatar Internal Medicine, Cardiology Section, Ahmed Maher Teaching Hospital, Cairo, Egypt aymanco65@yahoo.com.
Insights
Heart failure with preserved ejection fraction (HFPEF) patients had better outcomes than those with reduced ejection fraction (HFrEF). Early use of evidence-based medications may improve hospital outcomes for HFPEF patients.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Heart failure (HF) is a complex syndrome with diverse clinical presentations.
- Distinguishing between HF with preserved ejection fraction (HFpEF) and HF with reduced ejection fraction (HFrEF) is crucial for management.
- HFpEF constitutes a significant portion of HF cases, yet its characteristics and outcomes require further elucidation.
Purpose of the Study:
- To analyze the clinical presentation and outcomes of patients with HFpEF.
- To compare outcomes between HFpEF and HFrEF.
- To identify predictors of mortality in HF patients.
Main Methods:
- Retrospective analysis of 2212 HF patients from 2003 to 2013.
- Patients categorized into two groups based on left ventricular ejection fraction (LVEF): Group 1 (LVEF <50%) and Group 2 (LVEF ≥50%).
- Multivariate analysis employed to identify independent predictors of mortality.
Main Results:
- 20% of HF patients were classified as HFpEF (Group 2).
- HFpEF patients were more likely to be older, female, Arab, hypertensive, and obese.
- HFpEF was associated with lower in-hospital cardiac arrest, shock, and mortality rates compared to HFrEF.
- Independent predictors of mortality included age, ST-elevation myocardial infarction, and lack of specific medication use.
Conclusions:
- HFpEF is associated with a less severe clinical presentation and better short-term outcomes compared to HFrEF.
- Patient demographics and comorbidities differ significantly between HFpEF and HFrEF groups.
- Early administration of evidence-based medications may contribute to improved hospital outcomes in HF patients, including those with HFpEF.
Abstract:
We analyzed the clinical presentation and outcomes (from 2003 to 2013) of heart failure (HF) with apparently normal systolic function (HFPEF). Based on the echocardiographic left ventricular ejection fraction (LVEF), patients were divided into 2 groups, group 1 (<50%) and group 2 (≥50%). Of 2212 patients with HF, 20% were in group 2. Patients in group 2 were more likely to be older, females, Arabs, hypertensive, and obese (P = .001). Patients in group 1 were mostly Asians and had more troponin-T positivity (P = .001). Inhospital cardiac arrest, shock, and deaths were significantly greater in group 1. On multivariate analysis, age, ST-segment elevation myocardial infarction, lack of on-admission β-blockers, and angiotensin-converting enzyme inhibitors use were independent predictors of mortality. HFPEF is associated with less mortality compared to those who presented with reduced LVEF. On admission, use of evidence-based medications could in part predict this difference in the hospital outcome.
More Related Videos
Related Concept Videos
Heart Failure II: Pathophysiology
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure III: Clinical Manifestations
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy

